Product Information
NORETH-EE-FE 1.5-0.03 MG(21)-75 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1382 per EA under NDC 00378728853. Its NADAC has been published 342 times since Feb 5, 2020.
FDA first approved this application on Feb 20, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378728853
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202741FDA Approved
2/20/2015
TE Code
AB
On Market Since
12/16/2019
Price Statistics
The NADAC for NORETH-EE-FE 1.5-0.03 MG(21)-75 has been published 342 times since Feb 5, 2020, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.3905 (Apr 15, 2020) |
| All-time low | $0.1170 (May 22, 2024) |
| 52-week high | $0.1575 |
| 52-week low | $0.1303 |
| Median price | $0.1769 |
| Average price | $0.2178 |
| Largest weekly change | +29.4% (Jun 19, 2024) |
| Weeks tracked | 342 |
| Tracking since | Feb 5, 2020 |
1W
N/A
1M
N/A
3M
-2.2%
6M
+0.8%
1Y
-9.9%
3Y
-14.6%
5Y
-57.0%
All
-63.6%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORETH-EE-FE 1.5-0.03 MG(21)-75?
The current National Average Drug Acquisition Cost (NADAC) for NORETH-EE-FE 1.5-0.03 MG(21)-75, manufactured by Mylan Pharmaceuticals Inc., is $0.1382 per EA (NDC 00378728853), effective Aug 19, 2026.
How has the price of NORETH-EE-FE 1.5-0.03 MG(21)-75 changed over time?
Over the history we have for it, the NADAC for NORETH-EE-FE 1.5-0.03 MG(21)-75 has declined 63.6%. It has been tracked across 342 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for NORETH-EE-FE 1.5-0.03 MG(21)-75?
Since Feb 5, 2020, the NADAC for NORETH-EE-FE 1.5-0.03 MG(21)-75 has ranged from a low of $0.1170 (May 22, 2024) to a high of $0.3905 (Apr 15, 2020), with a median of $0.1769 per EA.
Are there cheaper alternatives to NORETH-EE-FE 1.5-0.03 MG(21)-75?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BLISOVI FE 1-20 TABLET, is $0.1287 per EA — about 7% below NORETH-EE-FE 1.5-0.03 MG(21)-75.
Who manufactures NORETH-EE-FE 1.5-0.03 MG(21)-75?
NORETH-EE-FE 1.5-0.03 MG(21)-75 (NDC 00378728853) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.